Innovation, Access to Medicines & Global Governance (GHP 554/SUP-517M), cross-listed between the Harvard School of Public Health and Kennedy School of Government, will explore policy issues related to health technology innovation and access to medicines in developing countries. In particular it will address the global governance challenges related to securing access to existing medicines while also promoting innovation of new medicines for the specific health needs of developing countries.
Global Health Governance, Law and Politics (HTH SCI 4LD3) surveys contemporary issues and debates in global health governance from an interdisciplinary perspective. Theory converges with practice as students examine the historical development of global health, its regulatory framework (e.g., global health law, human rights and ethics), principal coordinating mechanisms (e.g., multilateral organizations, partnerships and diplomacy) and emerging challenges to its effective governance (e.g., multinational corporations, corruption, globalization, trade and intellectual property).
Global Health Advocacy (HTH SCI 4ZZ3) aims to foster an understanding of the complexity of today’s most pressing global health challenges and the ways that various actors work to overcome them. Global health is not studied as an altruistic goal, but rather as a complex domain of political praxis with an ever-expanding cast of players, divergent interests and hidden agendas.